ULTRAGENYX

Company

Ultragenyx Pharmaceutical Inc.

Filed

February 14, 2014

Accession Number

0000315066-14-002671

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →